EGF and infection: Results in the clinical setting, where wounds were treated with recombinant EGF and platelet‐rich plasma (PRP); analyzing the susceptibility profiles of S. aureus and P. aeruginosa isolates, showing that patients treated with EGF had no infections during the follow‐up period, compared to 28/43 infections in patients treated with PRP;25 offering an interesting perspective of an immunomodulatory effect of local EGF.